BOLT
Bolt Biotherapeutics, Inc. Common StockRecent alerts on BOLT
All signals →
News
Bolt Biotherapeutics faces Nasdaq delisting risk By Investing.com - Investing.com Australia
14d ago
News
Bolt Biotherapeutics GAAP EPS of -$4.31 misses by $1.46, revenue of $0.03M misses by $1.47M
20d ago
SEC filing
BOLT Reports $2.5M Q4 Rev, $7.7M FY Rev, $31.8M Cash, $5.0M Q4 R&D, $28.5M FY R&D, BDC-4182 Phase 1 Data 3Q2026
81d ago
Insider trade
Purchase by William P. Quinn (President, CEO and CFO)
104d ago
Insider trade
Purchase by Sarah Nemec (Senior VP, Finance and PAO)
104d ago
Scanner
Unusual volume (7.8x average)
124d ago
Get push alerts for BOLT
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS